Saturday 17 October 2026
Export APYX’s income statement to Excel — free account
Apyx Medical Corporation
APYX Healthcare Medical Devices
Apyx Medical Corporation’s revenue for fiscal 2025 (year ended December 2025) was $52.8 million, up 9.86% from fiscal 2024. In the quarter to June 2026, revenue grew 22.1%, EPS grew 22.2%, free cash flow fell 137.4% and total debt rose 2.74%, each against the same quarter a year earlier.
2.55
0.01
−0.39%
Follow APYX
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
4 | 2 | 4 | 2 | 4 | 4 | 3 | 4 | 4 | 3 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.37 | 3.37 | 3.37 |
P/S ratio |
2.72 | 1.17 | 1.77 | 1.95 | 9.07 | 8.89 | 10.21 | 13.06 | 13.06 | 13.06 |
Altman Z-Score |
1.10 | (0.39) | 0.89 | 2.58 | 18.54 | 14.87 | 13.50 | — | — | — |
Altman Z″-Score (non-manufacturers) |
(0.11) | (0.95) | 1.61 | 1.47 | 6.38 | 9.87 | 9.44 | 16.18 | 0.08 | 2.72 |
P/FCF ratio |
0.00 | 0.00 | 62.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
(2.63) | (2.72) | (3.48) | (2.57) | (2.58) | (1.30) | (0.35) | (1.86) | (3.99) | (0.79) |
P/Operating CF |
(56.85) | (19.12) | (41.79) | (19.20) | 2,056.71 | (242.21) | (88.66) | (12.08) | (12.08) | (12.08) |
P/B ratio |
9.70 | 3.92 | 3.43 | 2.30 | 8.15 | 3.86 | 4.04 | 2.50 | 2.50 | 2.50 |
Price to Tangible BV |
9.82 | 3.97 | 3.46 | 2.31 | 8.18 | 3.87 | 4.06 | 2.51 | 2.51 | 2.51 |
EV/Sales |
2.95 | 1.40 | 1.74 | 1.73 | 8.44 | 7.40 | 8.16 | 8.38 | 8.38 | 8.38 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(19.48) | (3.73) | (17.32) | (3.80) | (39.20) | (12.76) | (12.47) | (6.70) | (6.70) | (6.70) |
EV/FCF |
(17.10) | (3.58) | 61.22 | (3.62) | (36.66) | (12.31) | (11.65) | (6.58) | (6.58) | (6.58) |
Quick Ratio |
4.15 | 4.40 | 4.53 | 2.40 | 3.94 | 6.47 | 5.56 | 9.68 | 2.60 | 3.79 |
Current Ratio |
5.00 | 5.26 | 5.52 | 3.63 | 4.60 | 7.22 | 6.23 | 10.43 | 3.77 | 5.03 |
Net Debt/EBITDA |
(0.54) | (0.12) | 0.63 | 0.45 | 2.28 | 2.17 | 2.90 | 5.74 | 0.61 | 1.16 |
Debt/Assets |
52.16% | 52.32% | 41.95% | 0.14% | 0.03% | 0.25% | 0.50% | 0.15% | 8.37% | 8.07% |
Debt/Equity |
2.35 | 2.37 | 1.23 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.12 | 0.11 |
Asset Turnover |
0.80 | 0.67 | 0.80 | 0.74 | 0.68 | 0.35 | 0.31 | 0.26 | 0.31 | 0.27 |
Operating CF/Net income |
0.71 | 0.77 | 0.28 | 0.87 | 0.69 | 1.35 | 0.94 | (0.33) | 0.73 | 0.72 |
Capex/Depreciation |
(1.70) | (1.21) | 9.73 | (1.13) | (0.80) | (0.65) | (1.73) | (0.54) | (0.90) | (0.39) |
Interest Coverage |
(1.15) | (3.19) | (6.96) | (1,570.80) | (1,444.80) | (436.59) | (2,608.62) | (137.27) | (102.10) | (72.10) |
| (76.88%) | (113.74%) | (57.83%) | (50.51%) | (25.74%) | (17.61%) | (24.88%) | 114.86% | (20.98%) | (15.92%) | |
| (17.03%) | (32.57%) | (28.57%) | (38.48%) | (21.24%) | (14.98%) | (21.81%) | 98.84% | (15.32%) | (11.87%) | |
ROIC |
(22.44%) | (71.30%) | (65.34%) | (53.21%) | (38.99%) | (56.73%) | (101.36%) | (98.67%) | (62.17%) | (51.51%) |
Return on Tangible Assets |
(22.81%) | (49.18%) | (31.43%) | (61.20%) | (28.04%) | (18.74%) | (27.74%) | 72.08% | (22.39%) | (14.25%) |
Average Days of Receivables |
115.87 | 117.46 | 97.77 | 149.62 | 159.21 | 228.24 | 124.70 | 111.67 | 173.23 | 195.89 |
Research and Development Expense of Revenue |
6.38% | 10.56% | 10.39% | 10.21% | 8.91% | 14.15% | 13.21% | 15.35% | 18.97% | 11.71% |
Selling, General and Administrative Expense of Revenue |
68.35% | 89.65% | 92.21% | 108.18% | 90.13% | 121.49% | 128.32% | 135.82% | 184.70% | 175.47% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.05 |
Share Based Compensation of Revenue |
3.79% | 8.34% | 9.77% | 15.05% | 10.49% | 15.19% | 12.68% | 13.39% | 8.51% | 9.17% |
Graham Net Nets |
0.04 | 0.11 | 0.20 | 0.33 | 0.10 | 0.23 | 0.22 | 0.37 | 0.37 | 0.37 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10.57 | 0.00 | 0.00 |
Earnings Yield |
(7.71%) | (42.41%) | (20.22%) | (26.59%) | (3.43%) | (4.86%) | (6.62%) | 29.68% | 29.68% | 29.68% |
Free Cash Flow Yield |
(6.34%) | (33.42%) | 1.61% | (24.48%) | (2.54%) | (6.76%) | (6.86%) | (9.74%) | (9.74%) | (9.74%) |
Revenue per Share |
1.29 | 1.35 | 1.51 | 1.29 | 1.41 | 0.81 | 0.83 | 0.50 | 0.33 | 0.32 |
Operating CF per Share |
(0.19) | (0.51) | (0.15) | (0.59) | (0.30) | (0.47) | (0.54) | (0.63) | (0.12) | (0.10) |
Capex per Share |
(0.03) | (0.02) | 0.19 | (0.03) | (0.02) | (0.02) | (0.04) | (0.01) | (0.02) | (0.01) |
Free Cash Flow per Share |
(0.22) | (0.53) | 0.04 | (0.62) | (0.33) | (0.49) | (0.58) | (0.64) | (0.14) | (0.11) |
Cash per Share |
0.77 | 0.89 | 1.26 | 0.30 | 0.90 | 1.23 | 1.73 | 2.36 | 0.34 | 0.56 |
Shareholders Equity per Share |
0.36 | 0.40 | 0.78 | 1.09 | 1.57 | 1.87 | 2.09 | 2.63 | 0.70 | 0.96 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.36 | 0.40 | 0.78 | 1.09 | 1.57 | 1.87 | 2.09 | 2.63 | 0.70 | 0.96 |
Free Cash Flow |
(9.11) | (18.77) | 1.49 | (21.29) | (11.17) | (16.65) | (19.78) | (21.24) | (4.33) | (3.12) |
Working Capital |
46.77 | 45.72 | 57.62 | 31.12 | 47.53 | 56.94 | 64.42 | 81.22 | 16.57 | 21.27 |
Capital Expenditures |
(1.11) | (0.72) | 6.73 | (1.01) | (0.72) | (0.58) | (1.30) | (0.36) | (0.62) | (0.29) |
Net Current Asset Value |
6.46 | 5.93 | 18.04 | 28.99 | 46.03 | 55.84 | 63.25 | 81.08 | 13.59 | 17.65 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.02 | 0.02 | (0.13) | 0.02 | 0.01 | 0.02 | 0.05 | 0.02 | 0.06 | 0.03 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.28 | 0.30 | 0.36 | 0.13 | 0.14 | 0.14 | 0.11 | 0.12 | 0.12 | 0.11 |
Cash ROIC |
(11.19%) | (23.46%) | 1.43% | (44.30%) | (13.16%) | (15.71%) | (15.15%) | (12.83%) | (12.26%) | (7.05%) |
Accounts Receivable Turnover |
3.28 | 3.26 | 3.24 | 2.26 | 2.52 | 2.05 | 3.83 | 3.34 | 2.13 | 2.30 |
Accounts Payable Turnover |
6.98 | 7.04 | 6.91 | 5.80 | 7.20 | 5.17 | 4.74 | 3.85 | 2.05 | 2.63 |
Inventory Turnover |
2.45 | 2.14 | 1.71 | 1.66 | 2.75 | 2.24 | 2.23 | 1.56 | 0.63 | 0.61 |
Average Days of Payables |
56.37 | 50.93 | 53.25 | 63.35 | 64.38 | 54.03 | 97.35 | 89.88 | 176.37 | 158.30 |
Days of Inventory on Hand |
158.57 | 147.31 | 194.83 | 279.99 | 165.86 | 144.86 | 202.37 | 198.70 | 476.19 | 606.99 |
Average Receivables |
16.13 | 14.75 | 16.13 | 19.70 | 19.25 | 13.49 | 7.36 | 4.97 | 4.80 | 3.83 |
Average Payables |
2.84 | 2.66 | 2.69 | 2.65 | 2.07 | 1.97 | 1.93 | 1.50 | 1.59 | 1.41 |
Average Inventory |
8.08 | 8.74 | 10.86 | 9.29 | 5.41 | 4.56 | 4.11 | 3.71 | 5.22 | 6.06 |
Average Assets |
65.84 | 72.04 | 65.51 | 60.25 | 71.42 | 79.43 | 90.34 | 63.46 | 33.05 | 33.28 |
Average Common Equity |
14.58 | 20.63 | 32.36 | 45.90 | 58.93 | 67.56 | 79.22 | 54.60 | 24.13 | 24.81 |
Columns are period end dates